Cibc World Market Inc. Makes New $1.72 Million Investment in Molina Healthcare, Inc $MOH

Cibc World Market Inc. bought a new position in Molina Healthcare, Inc (NYSE:MOH) in the 2nd quarter, HoldingsChannel.com reports. The firm bought 7,516 shares of the company’s stock, valued at approximately $1,719,000.

Several other institutional investors and hedge funds also recently made changes to their positions in MOH. Torren Management LLC bought a new position in shares of Molina Healthcare during the fourth quarter valued at about $26,000. Physician Wealth Advisors Inc. grew its position in Molina Healthcare by 1,250.0% in the 1st quarter. Physician Wealth Advisors Inc. now owns 216 shares of the company’s stock worth $29,000 after purchasing an additional 200 shares in the last quarter. Quarry LP bought a new stake in Molina Healthcare in the 4th quarter worth about $32,000. Triumph Capital Management grew its position in Molina Healthcare by 4,625.0% in the 4th quarter. Triumph Capital Management now owns 189 shares of the company’s stock worth $33,000 after purchasing an additional 185 shares in the last quarter. Finally, SJS Investment Consulting Inc. increased its stake in Molina Healthcare by 504.9% in the 1st quarter. SJS Investment Consulting Inc. now owns 248 shares of the company’s stock valued at $33,000 after buying an additional 207 shares during the last quarter. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Molina Healthcare Price Performance

MOH opened at $198.97 on Friday. Molina Healthcare, Inc has a fifty-two week low of $121.06 and a fifty-two week high of $244.89. The firm has a 50-day moving average of $211.41 and a 200 day moving average of $179.49. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.68 and a current ratio of 1.68. The firm has a market cap of $10.39 billion, a P/E ratio of -1,105.33, a PEG ratio of 29.01 and a beta of 0.75.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, July 22nd. The company reported $1.51 EPS for the quarter, topping the consensus estimate of $1.39 by $0.12. The business had revenue of $10.87 billion for the quarter, compared to analyst estimates of $10.83 billion. Molina Healthcare had a negative net margin of 0.02% and a positive return on equity of 3.73%. The company’s revenue for the quarter was down 4.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $5.48 earnings per share. On average, research analysts expect that Molina Healthcare, Inc will post 5.29 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on MOH shares. Royal Bank Of Canada dropped their target price on shares of Molina Healthcare from $248.00 to $218.00 and set a “sector perform” rating on the stock in a research report on Friday, July 24th. Mizuho set a $215.00 target price on Molina Healthcare in a report on Monday, June 8th. Wall Street Zen raised Molina Healthcare from a “sell” rating to a “hold” rating in a research report on Saturday, May 2nd. Weiss Ratings lowered Molina Healthcare from a “sell (d+)” rating to a “sell (d)” rating in a report on Wednesday. Finally, Wells Fargo & Company cut their price objective on Molina Healthcare from $235.00 to $220.00 and set an “equal weight” rating on the stock in a research report on Tuesday, July 28th. Three equities research analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $202.44.

Molina Healthcare Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.